Concepedia

Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations

Tamás Szél, István Koncz, Norbert Jost, István Baczkó, Zoltán Husti, László Virág, Alexandra Bussek, Erich Wettwer, Ursula Ravens, Julius Gy. Papp,

European Journal of Pharmacology · 2011 · 35 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Charles Antzelevitch, Luiz Belardinelli, Andrew C. Zygmunt et al. · Circulation · 2004 · 678 citations · Full text

, , +17

Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Bernard Chaitman · JAMA · 2004 · 676 citations

, , +17

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

Bernard Chaitman, Sandra Skettino, John O. Parker et al. · Journal of the American College of Cardiology · 2004 · 564 citations

, , +13

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Benjamin M. Scirica, David A. Morrow, Hanoch Hod et al. · Circulation · 2007 · 441 citations · Full text

, , +17

Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation

Alexander Burashnikov, José M. Di Diego, Andrew C. Zygmunt et al. · Circulation · 2007 · 400 citations · Full text

, , +17